Long-Term Safety of PEGylated Coagulation Factor VIII in the Immune-Deficient Rowett Nude Rat
Joint Authors
Rasmussen, Caroline E.
Nowak, Jette
Larsen, Julie M.
Moore, Emma
Bell, David
Liu, Kai Chiu
Sorensen, Nanna Skall
Kappers, Wendela A.
Krogh-Meibom, Thomas
Offenberg, Hanne
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-13, 13 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-03-28
Country of Publication
Egypt
No. of Pages
13
Main Subjects
Abstract EN
Turoctocog alfa pegol (N8-GP) is a glycoPEGylated human recombinant factor VIII for the treatment of hemophilia A.
The safety profile of rFVIII, and polyethylene glycols (PEG) technology, is well-established.
Conducting long-term toxicity studies in animals using human proteins can be complicated by anti-drug antibody (ADA) development.
To evaluate long-term safety of N8-GP, 26- and 52-week toxicity studies were conducted in immune-deficient rats dosed intravenously every fourth day with 0, 50, 150, 500, or 1200 IU/kg N8-GP.
Observations included clinical observations, body weight, ophthalmoscopy, hematology, chemistry, coagulation, urinalysis, toxicokinetics, antibody analysis, and macroscopic/microscopic organ examination.
Immunohistochemical staining examined the distribution of PEG in the brain.
No adverse test item-related findings were seen and PEG was not detected in the brain.
Exposure was confirmed for ~75% of the animals dosed with 500 and 1200 IU/kg N8-GP; the high lower limit of quantification of the bioanalysis assay prevented confirmation of exposure in the lower doses.
A small number of animals developed ADAs, and the proportion of animals surviving until scheduled termination was >80%.
N8-GP was well tolerated, and the immune-deficient rat proved suitable for testing long-term toxicity of human proteins that are immunogenic in animals.
American Psychological Association (APA)
Rasmussen, Caroline E.& Nowak, Jette& Larsen, Julie M.& Moore, Emma& Bell, David& Liu, Kai Chiu…[et al.]. 2017. Long-Term Safety of PEGylated Coagulation Factor VIII in the Immune-Deficient Rowett Nude Rat. Journal of Toxicology،Vol. 2017, no. 2017, pp.1-13.
https://search.emarefa.net/detail/BIM-1187909
Modern Language Association (MLA)
Rasmussen, Caroline E.…[et al.]. Long-Term Safety of PEGylated Coagulation Factor VIII in the Immune-Deficient Rowett Nude Rat. Journal of Toxicology No. 2017 (2017), pp.1-13.
https://search.emarefa.net/detail/BIM-1187909
American Medical Association (AMA)
Rasmussen, Caroline E.& Nowak, Jette& Larsen, Julie M.& Moore, Emma& Bell, David& Liu, Kai Chiu…[et al.]. Long-Term Safety of PEGylated Coagulation Factor VIII in the Immune-Deficient Rowett Nude Rat. Journal of Toxicology. 2017. Vol. 2017, no. 2017, pp.1-13.
https://search.emarefa.net/detail/BIM-1187909
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1187909